Article
The role of IL18-607C>A and IL18-137G>C promoter polymorphisms in antidepressant treatment phenotypes: A preliminary report.
Neuroscience letters - 27 May 2016
Santos Marlene, Carvalho Serafim, Lima Luís, Mota-Pereira Jorge, Pimentel Paulo, Maia Dulce, Correia Diana, Gomes Sofia, Cruz Agostinho, Medeiros Rui
Abstract excerpt
Recent studies suggest that immune activation and cytokines, such as IL-18, are involved in depression. IL-18 is expressed in brain and is increased in patients with moderate to severe depression. In this study we aim to evaluate the role of IL18-607C>A and IL18-137G>C promoter polymorphisms in antidepressant treatment phenotypes, specifically relapse and treatment resistant depression (TRD). We genotyped the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
